Serotonin Antagonism in the Treatment of Systemic Hypertension: The Role of Ketanserin
- 1 March 1988
- journal article
- Published by Elsevier in Medical Clinics of North America
- Vol. 72 (2) , 501-522
- https://doi.org/10.1016/s0025-7125(16)30780-5
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Cardiovascular profile and hypotensive mechanism of ketanserin in the rabbit.Hypertension, 1985
- Ketanserin in essential hypertension: a double-blind, placebo-controlled studyPostgraduate Medical Journal, 1985
- Effects of Serotonin on the Cardiopulmonary Circulatory System With and Without 5-HT2-Receptor Blockade by KetanserinJournal of Cardiovascular Pharmacology, 1985
- Ketanserin and Red Blood Cell Sodium Content in HypertensionJournal of Cardiovascular Pharmacology, 1985
- Serotonergic Mechanisms in Isolated Human Peripheral Arteries and VeinsJournal of Cardiovascular Pharmacology, 1985
- Continuous Inhibition of Platelet S2-Serotonergic Receptors During Chronic Administration of Ketanserin in HumansJournal of Cardiovascular Pharmacology, 1985
- Platelet Hypersensitivity to Serotonin After Prolonged Ketanserin Intake?Journal of Cardiovascular Pharmacology, 1985
- Effect of Ketanserin on the Hyperreactivity of Platelets to 5-Hydroxytryptamine in Patients with Cardiovascular DiseasesJournal of Cardiovascular Pharmacology, 1985
- Ketanserin in HypertensionActa Medica Scandinavica, 1983
- The Antihypertensive Effects of a Pure and Selective Serotonin-Receptor Blocking Agent (R 41 468) in Elderly PatientsAngiology, 1981